HCA Holdings (HCA) to See Plenty of Buy Ratings -Cramer
Tweet
Share
E-mail
Get Alerts HCA Hot Sheet
Price: $436.48 -0.37%
Rating Summary:
24 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
24 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Jim Cramer, host of CNBC's Mad Money, admitted Monday there is a shortage of quality healthcare stocks, but one play is recent IPO HCA Holdings Inc. (NYSE: HCA).
Cramer noted that HCA's IPO was hard to get into early, but the stock is up just 10 percent since the offering and there is still time to buy. Getting in on an IPO after the fact is not a recommendation usually made by the eccentric Wall Street personality.
HCA is the largest non-governmental healthcare company in the U.S., operating 164 hospitals in 20 states and England.
Cramer expects plenty of Buy ratings as analysts start to cover the stock, adding the stock is one of the few to benefit from "Obamacare," as HCA does better with more people being insured.
Shares of HCA are up 1.48 percent to $33.53 in premarket trade on Tuesday.
Cramer noted that HCA's IPO was hard to get into early, but the stock is up just 10 percent since the offering and there is still time to buy. Getting in on an IPO after the fact is not a recommendation usually made by the eccentric Wall Street personality.
HCA is the largest non-governmental healthcare company in the U.S., operating 164 hospitals in 20 states and England.
Cramer expects plenty of Buy ratings as analysts start to cover the stock, adding the stock is one of the few to benefit from "Obamacare," as HCA does better with more people being insured.
Shares of HCA are up 1.48 percent to $33.53 in premarket trade on Tuesday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts HCA Healthcare Inc (HCA) at Outperform
- AutoZone (AZO) PT Lowered to $4,230 at UBS Following 'Underwhelming' Q4 Print
- Pepsico (PEP) PT Lowered to $161 at BNP Paribas Exane, 'Expect Renewed Calls for Greater Urgency in NA'
Create E-mail Alert Related Categories
Analyst Comments, Trader TalkRelated Entities
Jim CramerSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
